23 results
6-K
EX-99.1
PRFX
PainReform Ltd.
9 Jul 24
Extraordinary General Meeting of Shareholders to Be
4:30pm
due to his significant experience leading and growing companies in the pharmaceutical industry and his significant leadership experience. His … experience leading the company’s management and the depth of his knowledge of our business enable him to provide valuable leadership on complex business
6-K/A
EX-99.1
PRFX
PainReform Ltd.
4 May 23
Annual General Meeting of Shareholders to Be
8:19am
leading and growing companies in the pharmaceutical industry and his significant leadership experience. His experience leading the company’s management … and the depth of his knowledge of our business enable him to provide valuable leadership on complex business matters that we face on an ongoing basis
6-K
EX-99.1
PRFX
PainReform Ltd.
3 May 23
Annual General Meeting of Shareholders to Be
5:25pm
and growing companies in the pharmaceutical industry and his significant leadership experience. His experience leading the company’s management … and the depth of his knowledge of our business enable him to provide valuable leadership on complex business matters that we face on an ongoing basis.
Efi
6-K
EX-99.1
PRFX
PainReform Ltd.
25 Nov 22
Annual General Meeting of Shareholders to Be
4:30pm
in the pharmaceutical industry and his significant leadership experience. His experience leading the company’s management and the depth of his … knowledge of our business enable him to provide valuable leadership on complex business matters that we face on an ongoing basis.
Efi Cohen-Arazi
6-K
EX-99.1
z7pxw aatwe
29 Jul 22
Investor Presentation July 2022
4:30pm
6-K
EX-99.1
l7o6mkzom3 ob
27 Oct 21
Annual General Meeting of Shareholders to Be
4:40pm
6-K
EX-99.3
egqs1ov4a3 br
13 May 21
PAINREFORM LTD. Condensed UNAUDITED FINANCIAL STATEMENTS
9:18am
6-K
EX-99.1
i4tav0nadz2
18 Mar 21
PainReform Provides Year-End Business Update and Reports Progress Towards
10:36am
20-F
nygmbdrb cgp85c8
18 Mar 21
Annual report (foreign)
9:03am
6-K
EX-99.1
1f09i 8jwkl
5 Jan 21
Investor Presentation January 2021
4:15pm
424B3
ai7co7s zw434q
25 Nov 20
Prospectus supplement
11:12am
6-K
EX-99.1
5sk3npm2 emgy3n8
25 Nov 20
PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer
10:08am
424B4
hladixjs
2 Sep 20
Prospectus supplement with pricing info
4:09pm
F-1/A
swbrh
31 Aug 20
Registration statement (foreign) (amended)
6:06am
F-1/A
mx1xwkgwfk mhw
24 Aug 20
Registration statement (foreign) (amended)
12:15pm
F-1/A
ggho2m
10 Aug 20
Registration statement (foreign) (amended)
4:15pm
F-1/A
pv341ji xu37
5 Aug 20
Registration statement (foreign) (amended)
1:26pm
F-1
kkvni
30 Jun 20
Registration statement (foreign)
5:16pm